Assignee
INSTITUTE FOR MYELOMA & BONE CANCER RES
US·3 granted patents·6 citations·filing 2014–2018
Top patents by PatentIndex Score
3 records- 0183US10126301B2Diagnostic, prognostic, and monitoring methods for multiple myeloma, chronic lymphocytic leukemia, and B-cell non-hodgkin lymphomaINSTITUTE FOR MYELOMA & BONE CANCER RES·Filed 2014·Granted Nov 13, 2018·5 cites·14 claims
- 0267US10363260B2Anti-cancer effects of JAK2 inhibitors in combination with thalidomide derivatives and glucocorticoidsINSTITUTE FOR MYELOMA & BONE CANCER RES·Filed 2015·Granted Jul 30, 2019·1 cites·24 claims
- 0363US12174189B2Diagnostic, prognostic, and monitoring methods for chronic lymphocytic leukemiaINSTITUTE FOR MYELOMA & BONE CANCER RES·Filed 2018·Granted Dec 24, 2024·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when INSTITUTE FOR MYELOMA & BONE CANCER RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →